Rochester,NY 8/31/2009 10:57:45 PM
AVI Biopharma, Inc. AVII, to Present Leading PPMO Drug Delivery Technology at Upcoming Scientific Meetings
AVI Biopharma, Inc.
AVI BioPharma, Inc., a developer of RNA-based drugs, today announced that Hong Moulton, Ph.D., Director of Discovery Research, will give oral presentations highlighting improved analogues of AVI's phosphorodiamidate morpholino oligomer (PMO) chemistry at two upcoming scientific meetings.
At the 3rd Intracellular Delivery of Therapeutic Molecules: From Bench to Bedside, taking place in Montpellier, France, Dr. Moulton will give a presentation titled "Targeted Gene Expression in vivo: Cell Penetrating Peptides Make Antisense Work," as part of the session on applications of delivery systems on Sept. 2, 2009. This conference, designed to bring together leading scientists in the field of cell-penetrating peptides and non viral delivery systems, is celebrating the 15 year anniversary of the discovery of cell-penetrating peptides.
At the Targeted Drug Delivery Conference, taking place in Lausanne, Switzerland, Dr. Mouton will present on "Cell Penetrating Peptidomorpholino Conjugates" on Sept. 3, as part of the peptide-bases delivery session.
About Stock Einstein
StockEinstein uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Disclaimer: Full disclaimer at http://StockEinsteain.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinsteain, nor any of its affiliates are registered investment advisors or broker dealers.
